![Best Practices for Cardiovascular Disease Prevention Programs](https://www.cdc.gov/dhdsp/pubs/guides/best-practices/images/bpg-cover.jpg)
![](https://phgkb.cdc.gov/PHGKB/images/Whats_new.jpg)
Last Posted: Feb 09, 2018
- Best Practices for Cardiovascular Disease Prevention Programs
- Casey's Story A Family History of Heart Disease
the FH Foundation, Jan 2018 - CYP2C19 and ABCB1 genetic polymorphisms correlate with the recurrence of ischemic cardiovascular adverse events after clopidogrel treatment.
Hou Xumin et al. Journal of clinical laboratory analysis 2018 Feb - Heart disease risk information, encouragement, and physical activity among Mexican-origin couples: Self- or spouse-driven change?
Skapinsky Kaley F et al. Translational behavioral medicine 2018 Jan 8(1) 95-104 - Pharmacogenomic Impact of CYP2C19 Variation on Clopidogrel Therapy in Precision Cardiovascular Medicine.
Brown Sherry-Ann et al. Journal of personalized medicine 2018 Jan 8(1) - The cost-effectiveness of screening strategies for familial hypercholesterolaemia in Poland.
Pelczarska Aleksandra et al. Atherosclerosis 2018 Jan 270132-138
No hay comentarios:
Publicar un comentario